This bill amends the Workforce Innovation and Opportunity Act by inserting a statutory definition of “evidence-based” into 29 U.S.C. 3102 and by changing state plan content requirements in 29 U.S.C. 3112(b)(1). The definition creates three evidentiary tiers—strong, moderate, and promising—based on the type of study demonstrating statistically significant effects, and it also provides an alternative pathway that relies on a research-based rationale plus ongoing evaluation.
The measure also requires State plans to describe the extent to which activities are evidence-based and to explain strategies the State will use to prioritize funding of evidence-based programs through the funds reserved under WIOA section 128(a). For compliance officers, program managers, and providers, the bill standardizes what counts as evidence and pushes evaluation and documentation into routine planning and funding decisions without authorizing new federal funds for evaluation or scaling.
At a Glance
What It Does
Adds a new paragraph to WIOA’s definitional section (29 U.S.C. 3102) that specifies three tiers of evidence (experimental, quasi-experimental, and controlled correlational) and an alternative rationale-plus-evaluation pathway. Amends the state plan requirements in 29 U.S.C. 3112(b)(1) to require disclosure of how evidence-based activities are and a description of strategies to prioritize evidence-based programs using funds reserved under section 128(a).
Who It Affects
State workforce agencies preparing WIOA state plans, Local Workforce Development Boards and training providers that apply for statewide reserved funds under section 128(a), the Department of Labor in its review role, and independent evaluators hired to meet the statute’s evidence standards.
Why It Matters
The bill creates a uniform federal yardstick for what counts as evidence within WIOA, which will influence funding decisions, procurement preferences, and evaluation priorities. Even without new money, the change shifts administrative emphasis toward measurable program effects and makes evaluation capacity a competitive asset for providers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 922 inserts a clear, multi-part definition of “evidence-based” into WIOA. Under the new language, an activity or program qualifies as evidence-based if it shows a statistically significant improvement in participant or other relevant outcomes using one of three research standards: at least one well-designed experimental study, at least one well-designed quasi-experimental study, or at least one well-designed correlational study with statistical controls for selection bias.
The bill also creates an alternative route: a program can qualify if it rests on a research-backed rationale or positive evaluation and the sponsor commits to ongoing efforts to study its effects.
Beyond definitions, the bill edits the state plan content rules. States must now state in their WIOA plans the extent to which proposed activities meet the statutory evidence standard and must describe how they will prioritize funding of evidence-based programs when spending funds reserved under section 128(a) for statewide workforce activities.
That means states will need to map individual strategies and statewide initiatives to an evidence tier and explain prioritization criteria in the plan submission.Operationally, this pushes evaluation and documentation into everyday management. States and providers will need systems to catalog study designs, effect sizes, and controls; procurement and selection processes will likely incorporate evidence-tier criteria; and reserved statewide funds may be used not only to scale proven programs but also to support additional evaluation work.
The bill does not allocate new federal dollars for evaluation, so states will decide whether to reallocate section 128(a) or other flexible funds to build the necessary analytic capacity.Finally, the statutory text frames evidence in outcome terms—“statistically significant effect on improving participant outcomes”—which invites standard measurement and reporting choices that DOL will likely need to clarify in guidance. The alternative “rationale plus ongoing evaluation” pathway gives states and smaller innovators a route to participation, but it also creates ambiguity about what counts as “high-quality research findings” or “positive evaluation,” leaving interpretation and enforcement to later rulemaking or guidance.
The Five Things You Need to Know
The bill adds paragraph (72) to 29 U.S.C. 3102 defining “evidence-based” with two routes: an outcomes-based research route (three tiers) and a rationale-plus-ongoing-evaluation route.
The outcomes-based route requires at least one well-designed experimental study (strong), quasi-experimental study (moderate), or correlational study with statistical controls (promising) showing a statistically significant effect.
The alternative route allows programs to qualify on a documented research rationale or positive evaluation provided they include ongoing efforts to examine program effects.
Section 102(b)(1) of WIOA (29 U.S.C. 3112(b)(1)) is amended to require state plans to describe how much of the State’s activities are evidence-based and to explain strategies for prioritizing evidence-based programs using funds reserved under section 128(a).
The bill imposes documentation and prioritization obligations but does not appropriate additional federal funds; states and providers will likely shoulder evaluation and reporting costs.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Statutory definition of “evidence-based” with tiered research standards and an alternative pathway
This new paragraph lays out what “evidence-based” means inside WIOA. It establishes three evidence tiers tied to study design and requires that eligible studies demonstrate statistically significant effects on participant or other relevant outcomes. The provision also supplies a fallback: a research-based rationale or positive prior evaluation can qualify a program if the sponsor commits to ongoing efforts to study its effects. Practically, the text shifts debates about what counts as evidence from ad hoc guidance to statutory language; that reduces ambiguity but raises new questions about how DOL and states will interpret “well-designed,” “statistically significant,” and “high-quality research findings.”
State plan must disclose the extent to which proposed activities are evidence-based
The bill inserts a requirement that state plans describe the extent to which the activities in the plan are evidence-based under the new statutory definition. This is a disclosure and planning obligation: states must inventory programs and assign them to evidence categories in the plan narrative. For plan reviewers and auditors, that creates a tractable checklist item, but it also means states will need internal processes to validate claims about evidence levels during plan development and subsequent implementation.
Requirement to describe strategies to prioritize evidence-based programs for funds reserved under section 128(a)
The bill adds a specific subparagraph directing states to explain how they will prioritize funding evidence-based programs using funds reserved as described in WIOA section 128(a) (statewide workforce activities). It does not mandate spending levels or create new funding streams; instead, it requires a strategy statement in the state plan. That makes reserved, flexible funds a focal point for scaling or testing interventions that meet the evidence definition and for funding evaluations—but it also leaves open whether states will actually reallocate those funds to evaluation or scaling, since no appropriation accompanies the mandate.
This bill is one of many.
Codify tracks hundreds of bills on Employment across all five countries.
Explore Employment in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Participants in programs that already meet the higher evidence tiers — these programs will be more likely to receive prioritized funding and scale because they can demonstrate the required study designs and outcomes.
- Providers and intermediaries with existing rigorous evaluations — organizations that have invested in experimental or quasi‑experimental research will gain competitive advantage in state planning and procurement processes.
- Independent evaluators and research firms — demand for well-designed experimental and quasi-experimental studies and for ongoing program monitoring is likely to increase as states and providers seek to meet the statutory tests.
- State workforce agencies that want to build data-driven portfolios — the statutory clarity gives states a framework to justify scaling proven interventions and to defend funding choices to stakeholders and auditors.
Who Bears the Cost
- State workforce agencies — they must add documentation, validation, and plan-writing work to show the extent of evidence-based activities and to craft prioritization strategies, likely without new federal funds.
- Local Workforce Development Boards and smaller training providers — entities without existing rigorous evaluations may face reduced access to reserved statewide funds and will need to invest in evaluation capacity or partnerships to remain competitive.
- Program operators running innovative or locally tailored pilots — new or niche interventions that lack standard evaluation designs may be deprioritized unless they can justify a research rationale and commit to ongoing study.
- Grantees and providers who must produce or commission studies — commissioning well-designed experimental or quasi-experimental evaluations is costly and time-consuming, imposing financial and operational burdens.
- The Department of Labor — DOL will confront increased review and technical assistance demands to interpret the statute, approve plan narratives, and monitor whether states’ prioritization strategies are implemented as described.
Key Issues
The Core Tension
The central dilemma is between raising the bar for demonstrated program effects (to improve outcomes and public stewardship) and preserving flexibility to support local innovation and under-researched interventions; stricter evidence rules steer funding toward proven programs but can sideline smaller or newer approaches and impose evaluation costs that states and providers may not be able to absorb without new resources.
The statute tightens the evidentiary standard in a way that improves clarity but creates sharp implementation questions. Measuring a “statistically significant effect” requires agreement on outcomes, sample sizes, follow-up periods, and statistical models; states and DOL will need to harmonize definitions or else face inconsistent application across jurisdictions.
The requirement for at least one qualifying study per tier privileges programs that have already attracted research investment, which tends to favor larger providers and standard interventions over small, community-tailored approaches.
The bill’s alternative pathway—qualification based on a rationale plus ongoing evaluation—softens the bar but is imprecise. Terms like “high-quality research findings” and “positive evaluation” invite discretionary interpretation, creating room for uneven enforcement.
Meanwhile, the prioritization requirement focuses on funds reserved under section 128(a) but does not appropriate evaluation dollars or set concrete prioritization percentages, so actual behavior will depend on state choices and available flexible funding. That gap creates a risk of performative compliance—states describing prioritization strategies without reallocating funds or investing in the evaluation capacity needed to back up claims.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.